PISCATAWAY, N.J., June 18,
2024 /PRNewswire/ -- GenScript Biotech
Corporation, renowned for its relentless innovation in synthetic
biology and industry-leading gene synthesis services, is excited to
announce the launch of its newest offering, GenScript FLASH Gene
service, the ultra-fast sequence-to-plasmid (S2P) service. This
flagship offering addresses the urgent demand for delivering gene
constructs with unmatched speed, quality, and cost-efficiency.
With GenScript's FLASH Gene service, the delivery time from
sequence to plasmid construct is just four business days, making it
the fastest S2P service in the industry. This groundbreaking
service features a flat-rate pricing model starting at just
$89, covering gene synthesis,
cloning, and plasmid preparation. This advancement is poised to
significantly facilitate and accelerate research and discovery
efforts in the development of antibody drugs, vaccines, and gene
and cell therapies.
Continuing GenScript's commitment to the highest standards of
quality and reliability, GenScript's FLASH Gene service guarantees
plasmid yield and 100% sequence accuracy. This assurance empowers
scientists to focus entirely on their research with complete
confidence.
GenScript's FLASH Gene services will be offered from our newly
expanded facility in Piscataway, New
Jersey, where we delivered our first gene 22 years ago. We
are also making this service available to customers across the
globe, ensuring the same competitive pricing and rapid turnaround
times at all locations.
"We recognize the current market challenges and understand the
critical need to develop the FLASH Gene service to support our
customers in accelerating breakthroughs," said Ray Chen, Ph.D., President of the Life Science
Group at GenScript. "As the pioneer and leader in gene synthesis,
we are committed to delivering genes to researchers worldwide in
the fastest, most reliable, and efficient manner. Our team has put
extensive efforts into platform upgrades, automation, and process
optimization, enabling us to offer the groundbreaking FLASH Gene
service, the fastest and most cost-effective gene synthesis
service. It is our mission to continuously understand the evolving
needs of our customers, drawing insights from their feedback and
experiences. This commitment drives us to constantly refine our
technologies and processes, ensuring that we not only meet but
exceed the expectations of the researchers we serve. We are truly
grateful for the opportunity to contribute to the ongoing
advancements in scientific research."
For more information, visit FLASH Gene
Service or contact our customer support team.
About GenScript
GenScript Biotech Corporation (HK.1548) is a world leader in
technologies and services for life science R&D and
manufacturing. Built upon its solid DNA synthesis technology, the
company comprises four major business units: a life science
services and products business unit, a biologics contract
development and manufacturing organization (CDMO), an industrial
synthetic products business unit, and an integrated global cell
therapy company. GenScript accelerates scientific discovery and
therapeutic breakthroughs for its customers. Since its founding in
New Jersey, USA in 2002, GenScript
has expanded its operations to serve more than 200,000 customers
across 100 countries with a dedicated team of 6,900 employees. As
of December 31, 2023, GenScript's
services and products have been cited by 87,700 peer-reviewed
journal articles worldwide. Guided by its mission to make people
and nature healthier through biotechnology, GenScript strives to
become the most trustworthy biotech company in the world.
Media Contacts
Kay
Chuang
Head of Marketing, GenScript
kay.chuang@genscript.com
View original
content:https://www.prnewswire.com/news-releases/genscript-biotech-corporation-launches-flash-gene-service-the-fastest-and-most-affordable-gene-synthesis-solution-on-the-market-302176154.html
SOURCE GenScript Biotech Corporation